Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims



    Explore by Goal












     Quick Answer


    Author snapshot (science strength)
    Based on 2 listed publications, Perrakis shows strong biological mechanistic traction combining structural biology with functional cell-biology and quantified assays. Evidence appears strongest for (1) ATX/ENPP2–LPA structure–function synthesis and (2) MPS1 localization control via its N-terminal TPR module, supported by a resolved structure (PDB 4B94) and checkpoint-relevant cell phenotypes.



     Long Answer


    Author Review: Anastassis Perrakis
    Date context: Apr 01, 2026. Evidence used here is restricted to the two publications explicitly provided in your prompt.
    1) What I can & cannot verify from the provided input
    • Known from your prompt: 2 papers with DOIs, plus extracted structural/functional details and score-like fields (e.g., paper_scientific_quality_score).
    • Not verified here: OpenAlex h-index/citations, because the prompt’s OpenAlex query failed with a read timeout; I therefore do not treat those metrics as reliable.
    2) Evidence map (the two provided publications)
    Paper Topic (mechanism) Study type (from provided extraction) Key evidence strength signals (from provided extraction)
    10.1194/jlr.R046391
    β€œAutotaxin: structure-function and signaling” (2014, Journal of Lipid Research)
    		 Autotaxin (ATX/ENPP2) structure–function β†’ LPA receptor signaling; isoforms, localization, inhibitor concepts Thematic literature review synthesized with structural context (crystal structures referenced) Review focus includes ATX domain organization, LPA receptor coupling, and inhibitor classes; provided extraction flags structural evidence and unresolved mechanistic questions.
    10.1083/jcb.201210033
    β€œA TPR domain–containing N-terminal module of MPS1 is required for its kinetochore localization by Aurora B” (2013, Journal of Cell Biology)
    		 MPS1 localization checkpoint control: NTE + TPR module; Aurora B regulation; HEC1/NDC80 dependency Structural biology + cell biology with crystallography, mutant analysis, inhibitor tests, and localization/functional assays Provided extraction reports a 2.2 Γ… X-ray structure (PDB 4B94) plus functional localization/checkpoint readouts and Aurora B dependency tests.
    3) Visual synthesis: quality/scientific-strength signals from the provided extraction
    These bars only reflect the scoring fields present in your provided data (not new computation from raw experimental datasets).
    Score evidence anchors (inline citations)
    The review paper’s extracted synthesis of ATX domain architecture, LPA receptor signaling, and inhibitor feasibility is grounded in the provided summary of 10.1194/jlr.R046391. The structural/functional MPS1 paper’s extracted claimsβ€”TPR/NTE localization logic, 2.2 Γ… crystallography of a TPR-containing N-terminal module (PDB 4B94), and Aurora B dependenceβ€”are grounded in 10.1083/jcb.201210033.
    4) Scientific strength assessment (skeptical, mechanism-first)
    4.1 Strongest signal: mechanistic integration with structural constraints
    Perrakis’s provided publication set includes both (i) a structure–function signaling synthesis for a secreted enzyme/receptor axis (ATXβ†’LPAβ†’LPAR1-6) and (ii) a cell-signaling checkpoint mechanism tied to a specifically resolved structural module (MPS1 TPR/NTE) and its regulation by Aurora B.
    4.2 Where evidence is likely strongest vs weaker (review vs experimental)
    ATX/ENPP2 paper: Because it is a thematic review (not a single new primary dataset), the key strength is breadth and synthesis; the key weakness is that mechanistic β€œdelivery” questions (e.g., how structural features physically translate to receptor activation) may remain inferential and dependent on prior literature. MPS1 paper: The evidence is stronger because the prompt’s extraction includes crystallographic resolution metrics and multiple cell-based readouts (localization, checkpoint phenotypes) plus perturbation logic (mutants and Aurora B inhibition), which reduces the risk that the conclusions are purely correlational.
    5) Critical blind spots & plausible limitations (explicitly countering overreach)
    • Population/biology coverage is unknown: the prompt provides no comprehensive track record beyond these two papers, so generalizing β€œworld-class expertise” from this slice would be unjustified.
    • Review inference risk: for the ATX piece, mechanistic delivery/localization claims are necessarily constrained by the evidence available in the literature synthesized; review framing may over-emphasize well-studied structural/inhibitor lines and under-represent unresolved or negative findings.
    • Experimental context risk: for MPS1, the prompt’s extraction explicitly notes fragment-based crystallography and potential artifacts from overexpression/tagging and chemical inhibition off-target effects as plausible limitations.
    • Citation-metric uncertainty: the OpenAlex citation metrics were not retrievable due to a timeout in the prompt; therefore, citation-based assessments (h-index, total citations) cannot be treated as evidence here.
    6) Directed β€œexpertise profile” graph (what the evidence suggests)
    This network is a schematic mapping only from the two provided publications (no extra assumptions). It highlights recurring themes: structural modules, localization mechanisms, and signaling consequence.
    Evidence anchors for these thematic links:
    • ATXβ†’LPAβ†’LPAR signaling context is stated in the provided ATX review extraction.
    • MPS1 NTE-TPRβ†’Aurora B is explicitly central to the provided MPS1 extraction.
    7) Practical takeaway for a user
    If you are evaluating Perrakis as a scientific contributor, the provided evidence slice suggests strong capacity for:
    • Bridging protein structural features to cell-state outcomes (localization/checkpoint phenotypes in MPS1).
    • Synthesizing complex signaling axes (ATX–LPA) while explicitly noting unresolved mechanistic questions.
    Confidence is bounded because the prompt provides only two publications and does not provide citation metrics (h-index/citations) due to the OpenAlex timeout.


    Feedback:    

    Updated: April 01, 2026

     Hypothesis Graveyard


    A hypothesis that MPS1 Aurora B dependence is purely due to indirect microtubule/tension effects (without TPR-mediated localization control) is disfavored by the extraction’s claim that removing TPR abolishes Aurora B dependence of localization/checkpoint behavior.


    A hypothesis that isoform differences in ATX are irrelevant to functional outcomes is undermined by the extraction emphasizing isoform-specific localization mechanisms (e.g., HS-binding differences) and remaining isoform-specific in vivo questions.

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending